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ABSTRACT
Objectives: Concentrations of soluble ICAM-2, -3, -4 and syndecan-1 and -4 have not yet been marked in the peritoneal 
fluid of women with endometriosis. The aim of the study was to determine whether these molecules can participate in 
formation and development of endometriosis.
Material and methods: The study comprised of 80 women at the proliferative phase of the menstrual cycle, aged 21 to 
49 years (mean age 31. 3 ± 6. 7 years) undergoing laparoscopy, to determine the causes of primary infertility and to con-
firm or exclude endometriosis. The study group consisted of 60 women with endometriosis in the pelvis as confirmed by 
laparoscopy and histopathology. The reference group consisted of 20 women in whom no endometriosis. Concentrations 
of selected sICAM and syndecans in the peritoneal fluid were determined with the use of ELISA method.
Results: Decreased concentrations of sICAM-2 and increased concentrations of sICAM-3, sICAM-4 and syndnecan-1 and 
-4 were observed in the peritoneal fluid of women with endometriosis and compared with concentrations of this parameter 
in the reference group (p < 0.0001). Additionally, negative correlation was found between the concentrations of sICAM-3 and 
sICAM-2 among women with endometriosis. There was no statistically significant correlation between the concentration 
of sICAM-2 and sICAM-4, sICAM-3 and sICAM-4 and syndecan-1 and syndecan-4 in the examined women.
Conclusions: Changes in concentrations of all the evaluated molecules were observed in the peritoneal fluid in women 
suffering from endometriosis. Since they have a role in regulation of the immune response, in angiogenesis and apoptosis 
of the endometrial cells. 
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INTRODUCTION
Endometriosis is a chronic disease characterized by the 
presence of active mucous membrane of the uterus body, be-
yond its natural location [1, 2]. Etiopathogenesis of the disease 
is still unknown. Still unknown are the mechanisms underlying 
adhesion of endometrial cells to the peritoneum and enabling 
their movement to distant regions of the body, initiating de-
velopment of the ectopic tissue and ensuring its survival [3]. 
Therefore, among women with endometriosis, it is nec-
essary to conduct research into the role of the molecules 
responsible for intercellular interactions and the immune 
response [4–10]. Cell adhesion molecules ICAM (intercellular 
adhesion molecules) and syndecans participate in migration 
and adhesion of leukocytes and other body cells and in the 
process of differentiation and growth of all cells. They are 
indispensable in maintaining intercellular integrity and are 
involved in the process of angiogenesis and apoptosis [7, 10]. 
These molecules form an integral part of the cell membrane 
of many organs and tissues of the system, but they can also 
exist in a soluble form in biological fluids. Soluble forms 
are the result of enzymatic cleavage of extracellular do-
mains of molecules from the cell surface. This can be 
achieved by means of metalloproteinase-9 (MMP-9, matrix 
metalloproteinase-9), metalloproteinase-2 (MMP-2, 
matrix metaloproteinase-2), TNF-α-converting enzyme (TACE, 
tumor necrosis factor-α converting enzyme) and elastases 
[11–13]. Soluble adhesion molecules can change activity of 




the mechanisms of cell adhesion and migration to remote 
parts of the system. 
No studies have been carried out to assess concentra-
tions of the soluble forms: ICAM-2 (intercellular adhesion 
molecule-2, CD102), ICAM-3 (intercellular adhesion mol-
ecule-3, CD50), ICAM-4, syndecan-1 and 4 in the peritoneal 
fluid in women with endometriosis. 
Aim
The aim of the study was to determine whether selected 
soluble cell adhesion molecules and syndecans are involved 
in formation and development of endometriosis.
MATERIAL AND METHODS
The study comprised of 80 females aged 21–49 years 
(mean age 31.3 ± 6.7 years) undergoing laparoscopy to de-
termine causes of primary infertility. The examined women 
were patients of the Department and Clinical Ward of Gy-
naecology and Obstetrics, Professor. K. Gibiński University 
Clinical Centre, Medical University of Silesia in Katowice. 
The inclusion criteria were written, informed consent to 
participate in the study, regular menstrual cycles lasting 
28 ± 4 days, overall good health, diagnosis of primary infer-
tility, no history of the use of hormonal agents during the 
three months before laparoscopy, no history of autoimmune 
diseases as well as benign or malignant lesions in the ovary 
and the uterus. 
The exclusion criteria were as follows: failure to deliv-
er a written consent to participate in the study, irregular 
menstrual cycles (not lasting 28 ± 4 days), drug history of 
immunomodulators, hormonal medication, overall poor 
health, non-malignant or malignant changes in the ovary 
or in the uterus. 60 women aged 21–49 years (mean age 
31.9 ± 7.0 years) were enrolled in the study group, among 
them endometriosis in the small pelvis was diagnosed dur-
ing laparoscopy and then confirmed by histopathological 
examination. The extent and severity of endometrial chang-
es in the peritoneal cavity were evaluated according to the 
classification of the American Society of Fertility (rAFS), 
including the division into I, II, III and IV degree of endome-
triosis. Among 20 women, the first degree of endometriosis 
was found, among 16 women subjects- II stage, stage III 
was diagnosed among 15 women, while grade IV was diag-
nosed among nine women. The reference group consisted 
of 20 women aged 21–46 years (mean age 30.4 ± 6.1 years) 
who had no endometriosis or other pathological changes 
observed in the small pelvic region during laparoscopy. 
All women were informed about the purpose of the research 
and they expressed their consent to collection and use of 
their peritoneal fluid for scientific purposes. 
The test material was the peritoneal fluid collected dur-
ing laparoscopy from women in the proliferative phase of the 
menstrual cycle. Immediately after collection the peritoneal 
fluid was centrifuged at 2500 rpm. for 10 minutes at 4°C, in 
order to separate the fluid from the cells. After centrifugation, 
the supernatant was divided into small portions and stored 
at –80°C until the assays were made. The peritoneal fluid 
concentrations of the following soluble cell adhesion mol-
ecules were determined with the use of the Enzyme Linked 
Immunosorbent Assays (ELISA) by Diaclone SAS, France and 
Clound-Clone Corp., Houston, USA: sICAM-2 (sensitivity: 
0.2 U/ml), sICAM-3 (sensitivity: 0.3 ng/mL), sICAM-4 (sensi-
tivity: 0.35 ng/mL), syndecan-1 (sensitivityt: 4.94 ng/mL) and 
syndecan-4 (sensitivity: 0.125 ng/mL).
The obtained results were statistically analysed with 
the use of Statistica for Windows version 12.0 and MS Excel. 
The Shapiro-Wilk test was used to assess distribution of 
the obtained results. In case of the obtained results corre-
sponding to normal distribution, t-Student test was used for 
independent samples to analyse the results. The arithmetic 
mean (x???) and standard deviation (SD) were calculated 
for each parameter. In the case of the homogeneity principle 
of variance of the tested parameters, a one-way ANOVA 
analysis was used. The significance of differences was ad-
ditionally verified by means of the Rir Tukey post-hoc test. 
For given features which differed significantly, the nonpara-
metric methods were used to compare the results and the 
median and interquartile ranges were determined - the 
lower quartile (Q1) and the upper quartile (Q3). In this case, 
the Mann-Whitney U test and the Kruskal-Wallis RAN ANOVA 
test were used. In case of statistically significant differences, 
a multiple post-hoc test was used. For normal distribution, 
correlation between the tested parameters was verified us-
ing the Pearson’s correlation coefficient (r). If the assumption 
of normality of distribution was not met, the Spearman’s 
rank correlation coefficient (R) was calculated. The assumed 
significance level was p ≤ 0.05.
Ethical approval
The approval of the Bioethics Committee, e Medical 
University of Silesia in Katowice, Poland, No. NN-6501-57/07, 
of April 4, 2007 was obtained for the tests. 
RESULTS
In the peritoneal fluid of women with endometriosis 
a decrease in sICAM-2 concentration was found, as com-
pared to the concentration of this parameter in the reference 
group (p < 0.0001). The mean sICAM-2 concentration among 
women with endometriosis was 34.13 ± 16.84 (3.90–89.98), 
and in the reference group: 58.26 ± 8.44 (37.01–74.80). A sta-
tistically significant decrease in sICAM-2 concentration in 
peritoneal fluid of women with I, II and IV degree of the 
disease was demonstrated, as compared to concentrations 
of this parameter in the reference group (p < 0.0001 and 
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p < 0.0001 and p < 0.0001 respectively). In contrast, the 
concentration of sICAM-2 in the peritoneal fluid of women 
with stage III was not statistically reduced, comparing to 
concentrations of this parameter among females in the refer-
ence group. There was no statistically significant correlation 
between the concentration of sICAM-2 in the peritoneal 
fluid and the subsequent advancement of endometriosis 
among the examined women. The results are illustrated in 
Figure 1 and presented in Table 1.
Elevated concentrations of sICAM-3 were found in the 
peritoneal fluid of women with endometriosis, compar-
ing to concentrations of this parameter in the reference 
group (p < 0.0001). The mean sICAM-3 concentration among 
women with endometriosis was 18.63 ± 5.18 (10.87–37.64), 
comparing to the reference group: 11.86 ± 3.08 (5.84–19.95). 
Analysis of the results showed a statistically significant in-
crease in sICAM-3 concentration in the peritoneal fluid 
among women with I and IV stage of the disease and sta-
tistically significant increase in the concentration of the 
tested parameter among women with endometriosis II, 
comparing to sICAM-3 in the reference group (respectively 
p < 0.0001 and p < 0.0001 and p < 0.001). On the contrary, 
concentrations of sICAM-3 in the peritoneal fluid of women 
with stage III of the disease was not significantly increased 
comparing to the concentrations of this parameter among 
women in the reference group. The study showed no statisti-
cally significant correlations between the concentration of 
sICAM-3 in the peritoneal fluid and the successive stages 
of endometriosis. Negative correlation was found between 
sICAM-3 and sICAM-2 concentrations among women with 
endometriosis. The results are illustrated in Figures 2 and 3 
and presented in Table 2.
Table 1. sICAM-2 concentration in the peritoneal fluid of women at 
subsequent stages of endometriosis and women in the reference 
group
Examined group n
sICAM-2 concentration in the 
peritoneal fluid [U/mL]




I 20  6.27–50.01 30.17 ± 12.35*
II 16  5.75–57.19 37.06 ± 11.41*
III 15 27.78–89.98  49.59 ± 14.73**
IV 9  3.90–24.81  11.97 ± 6.90*
Women from the 
reference group 20 37.01–74.80  58.26 ± 8.44
n — group size; x — arithmetical mean; SD — standard deviation; 
*p < 0.0001 compared to women in the reference group; ** NS compared to 




















Figure 1. sICAM-2 concentration in the peritoneal fluid of women in 

























Figure 2. sICAM-3 concentration in the peritoneal fluid of women in 
the reference group and women with endometriosis
Figure 3. Linear regression curve illustrating the correlation between 


























An increase in sICAM-4 concentration was found among 
women with endometriosis, comparing to concentrations 
of this parameter in the reference group (p < 0.0001) and 
the mean sICAM-4 concentration was 0.89 (Q1: 0.39 and Q3: 
1.93 and 0.18–7.57), and in the reference group: 0.28 (Q1: 
0.13 and Q3: 0.39 and 0.05–0.53). Analysis of the results 
showed a significant increase in sICAM-4 concentration in 
the peritoneal fluid among women with stage I and II stage of 
the disease, as compared to concentrations of this parameter 
in the fluid of females in the reference group (p < 0.0001 and 
p < 0.0001 respectively). However, the concentration of 
sICAM-4 in the peritoneal fluid among women with stage III 
and IV was not statistically increased, comparing to concentra-
tions of this parameter among women in the reference group.
Moreover, a statistically significant negative correlation 
between sICAM-4 concentration and successive stages of 
the disease in the peritoneal fluid of the examined women 
(R = –0.633 and p < 0.0001) was demonstrated. There was no 
statistically significant correlation between the concentra-
tion of sICAM-2 and sICAM-4, sICAM-3 and sICAM-4 among 
the examined women. The results are illustrated in 
Figures 4 and 5 and presented in Table 3.
The tests revealed increased peritoneal fluid concentra-
tions of syndecan-1 among women with endometriosis, 
comparing to the concentrations of this parameter in the 
reference group (p < 0.0001). Mean concentration of synde-
can-1 reached 11.42 (Q1: 7.72 and Q3: 15.62 and 2.35–33.20), 
as compared the reference group: 4.28 (Q1: 2.80 and Q3: 
5.75 and 0.88–8.50). Analysis of the results showed a statis-
tically significant increase in syndecan-1 concentrations in 
the peritoneal fluid among women with stage I and IV, and 
statistically significant increase in the test parameter among 
the females with stage II of endometriosis, compared to syn-
decan-1 in the reference group (p < 0.0001 p < 0.0001 and 
p < 0.001). However, concentrations of syndecan-1 in the 
peritoneal fluid of women with stage III was not statistically 
Table 2. sICAM-3 concentration in the peritoneal fluid of women at 
subsequent stages of endometriosis and women in the reference 
group
Examined group n
sICAM-3 concentration in the 
peritoneal fluid [ng/mL]





I 20 12.24–23.43  18.52 ± 2.84* 
II 16 12.27–29.16 17.46 ± 4.90** 
III 15 10.87–26.48 15.97 ± 4.03*** 
IV 9 17.02–37.64 25.36 ± 6.22* 
Women in the 
reference group 20 5.84–19.95 11.86 ± 3.08 
n — group size; x — arithmetical mean; SD — standard deviation; 
*p < 0.0001 compared to women in the reference group; **p < 0.001 compared to 





















Table 3. sICAM-4 concentration in the peritoneal fluid of women at 


















I 20  0.96* 0.47–2.46 0.86 1,45 
II 16  2.73* 1.26–7.57 1.91 4,50 
III 15 0.39** 0.26–0.68 0.32 0,56 
IV 9 0.23** 0.14–0.52 0.19 0,28 
Women in the 
reference group 20  0.28 0.05–0.53 0.13 0.39 
n — group size; *p < 0.0001 compared to women in the reference group; **NS 
compared to women in the reference group
Figure 4. sICAM-4 concentration in the peritoneal fluid of women in 
the  reference group and women with endometriosis






















Figure 5. Linear regression curve illustrating the correlation between 
concentration of  sICAM-4 in the peritoneal fluid of women with 
endometriosis and the subsequent stages of disease
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increased comparing to concentrations of this parameter 
among women in the reference group. There was no statisti-
cal correlation between the peritoneal fluid concentrations 
of syndecan-1 in further stages of advanced endometriosis 
among the examined women. The results are illustrated in 
Figure 6 and presented in Table 4.
Increased peritoneal fluid syndecan-4 concentrations 
were observed in women with endometriosis, as com-
pared to concentrations of this parameter in the reference 
group (p < 0.0001). Mean concentration of syndecan-4 was 
16.66 ± 7.12 (1.72–42.03), and: 10.05 ± 3.65 (3.51–15.3) in 
the reference group. The statistical analysis showed a sig-
nificant increase in concentrations of syndecan-4 in the 
peritoneal fluid of women with stage I and a significant 
increase in the test parameter among women with stage 
II of the disease, as compared to syndecan-4 in the refer-
ence group (< 0.0001 and p < 0.01 respectively). However, 
concentrations of syndecan-4 in the fluid of women with 
stage III and IV was not statistically increased comparing 
to concentrations of this parameter among women in the 
reference group. In addition, a significant correlation was 
found between the concentrations of syndecan-4 in the 
peritoneal fluid and further stages of the disease among 
the examined women (R = –0.635 and p < 0.0001). There 
was no statistical correlation between concentrations of 
syndecan-1 and syndecan-4 in the evaluated females. The 
results are illustrated in Figures 7 and 8 and shown in Table 5.
DISCUSSION
The receptors for the ICAM-2 molecule are: LFA-1 integrin 
on leukocytes and DC-SIGN lectin (Dendritic Cell-Specyfic 
Intercellular adhesion molecule-3 grabbing Non-integ-


















p < 0.0001 Table 4. Syndecan-1 concentration in the peritoneal fluid of women at 
subsequent stages of endometriosis and women in the reference group
Examined 
group n
















I 20 14.85* 5.50–33.20 11.25 16.81 
II 16 10.66** 5.35–16.25 8.52 13.70 
III 15  3.61*** 2.35–10.41 2.65  7.60 




20  4.28  0.88–8.50 2.80  5.75 
n — group size; *p < 0.0001 compared to women in the reference group; 
**p < 0.001 compared to women in the reference group; ***NS compared to 
women in the reference groupFigure 6. Syndecan-1 concentration in the peritoneal fluid of women 




















Figure 7. Syndecan-4 concentration in the peritoneal fluid of women 
in the reference group and women with endometriosis
I II III IV





















                                                                                                  
 
 R = –0.635
p < 0.0001
Figure 8. Linear regression curve illustrating the correlation between 
concentration of syndecan-4 in the peritoneal fluid of women with 




the activity of lymphocytes and dendritic cells may modulate. 
Consequently, it may lead to incorrect recognition of the 
endometrial cells in ectopic sites. Amsellem et al. [11] studied 
participation of sICAM-2 in the process of cancer cell migra-
tion. According to the authors, the soluble ICAM-2 molecule 
facilitates migrating cells to overcome the vascular endothe-
lium barrier and to move to distant parts of the system. 
A soluble ICAM-3 molecule may cause impairment of 
LFA-1 receptor bonding to other ICAM molecules. As the 
ICAM-3 molecule is involved in both, antigen presentation 
and stimulation of lymphocytes, as well as in the effector 
phase of the immunological response, the increased con-
centration of the soluble form of this molecule in the perito-
neal fluid of women with endometriosis may contribute to 
impairment of both phases. The DC-SIGN receptor located 
on dendritic cells, connecting with the ICAM-3 molecule on 
virgin T lymphocytes, supports the diagnosis of the present-
ed antigen [17]. If sICAM-3 is released, the recognition and 
presentation of the antigen may be impaired [16]. Combin-
ing with the DC-SIGN receptor on NK cells and macrophages 
and with the LFA-1 receptor on CD8 + T lymphocytes, the 
soluble sICAM-3 molecule reduces activity of these cells. The 
effect of such combination may weaken or eliminate the cy-
totoxic activity directed against the target cells. It has been 
shown in endometriosis that peritoneal macrophages and 
NK cells show limited ability of eliminating the endometrial 
cells from the peritoneal cavity [18]. 
A negative correlation between the concentration of 
sICAM-3 and sICAM-2, shown in the study, may prove that 
these molecules compete for the binding site of the appro-
priate receptors, both on leukocytes and dendritic cells, as 
well as on vascular endothelial cells. This may contribute to 
abnormal adhesion of the immune system to the vascular 
endothelium and abnormal leukocyte migration into the 
sites where the ectopic cells of the endometrium were im-
Table 5. Syndecan-4 concentration in the peritoneal fluid of women 
at subsequent stages of endometriosis and women in the reference 
group
Examined group n
Syndecan-4 concentration in 





I 20 16.45–42.03 22.71 ± 6.40* 
II 16 8.15–23.16 15.50 ± 4.32** 
III 15 4.92–23.50 13.61 ± 5.42*** 
IV 9 1.72–19.17 10.39 ± 5.84*** 
Women in the reference 
group 20 3.51 – 15.31 10.05 ± 3.65
n — group size; x — arithmetical mean; SD — standard deviation; 
*p < 0.0001 compared to women in the reference group; **p < 0.001 compared to 
women in the reference group; ***NS compared to women in the reference group
planted. This may result in abnormal immune response to 
the ectopic endometrium cells [18–20]. 
Analysis of the results showed increased concentration 
of sICAM-4 in the peritoneal fluid of women with endome-
triosis, comparing to concentrations of this parameter in 
the reference group. This particularly concerned women 
with stage I and II of the disease. It may point to participa-
tion of sICAM-4, especially at the early stage of the dis-
ease. Lacking outflow, in endometriosis the menstrual red 
blood cells undergo haemolysis. It leads to the unveiling 
of phosphatidylserine and, due to the lack of its outflow, 
intensified expression of ICAM-4 molecule on red blood 
cells and the release of its soluble form. This contributes to 
the increased binding capacity of sICAM-4 on erythrocytes, 
integrin receptors located on vascular endothelium, mono-
cytes, leukocytes, platelets and NK cells and it promoting 
the risk of adhesion of other cells to its surface, perhaps also 
the ectopic endometrium cells.
Negative correlation between sICAM-4 concentrations 
in the peritoneal fluid of women with endometriosis and the 
subsequent stages of the disease was also demonstrated. 
It is possible that the increased concentration of sICAM-4 in 
the peritoneal fluid of women with endometriosis is due 
to the presence of active ectopic endometrium cells and 
indicative of the early stage of the disease. In contrast, the 
decrease in sICAM-4 concentration found in the perito-
neal fluid of women with endometriosis may suggest the 
presence of inactive and fibrotic endometriotic changes, 
observed in women with advanced endometriosis. 
The soluble syndecan-1 retains the activity of the mem-
brane form. For this reason, the molecule can compete with 
its counterpart on the surface of the cell, for the binding site 
of the appropriate receptor and modulate the biological 
functions of the cell. Binding soluble syndecan-1 to growth 
factors allows for cell proliferation. The presence of soluble 
syndecan-1 in the peritoneal fluid may therefore facilitate 
survival of the endometrial cells outside the uterine cavity. 
The expression of syndecan-1 has been demonstrated 
on endometrial cells. Schneider et al. [21], demonstrated 
participation of syndecan-1 in proliferation and invasiveness 
of the endometrial cells and in development of inflamma-
tion in women with endometriosis. The authors believe 
that syndecan-1 allows for implantation of these cells in 
the ectopic sites. According to the authors, the increase of 
cell invasiveness is because of syndecan-1 on secretion of 
interleukin-6 (interleucine-6) and modulation of the prote-
olysis process. Increased syndecan-1 concentrations in the 
peritoneal fluid, observed during the study in women with 
endometriosis, may point to participation of this molecule 
in the processes mentioned above. Relationship between 
the increased expression of the membranous form of syn-
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decan-1 on the endometrial cells and formation of endo-
metriosis was indicated by Cicinelli et al. [22].
Changes in concentrations of soluble syndecan-4 ob-
served in the study in women with endometriosis may result 
in increased proliferation of the smooth muscle cells in the 
blood vessels and in formation of their basement membrane 
[22]. Formation of new vessels is necessary for survival of the 
ectopic endometrium implants outside the uterine cavity. 
The syndecan-4 molecule plays an important role in repair of 
the damaged tissues. During skin regeneration, expression 
of syndecan-4 is increased in the granulation tissue on the 
endothelial cells and fibroblasts [23]. At stage IV endome-
triosis, the ectopic endometrium becomes fibrotic. Chelar-
iu-Raicu et al. [6] showed that syndecan-4 might participate 
in pathogenesis of endometriosis through the influence 
of this molecule on metalloproteinase-3, GTP-azaR1 and 
ATF-2 (activating transcription factor-2.) These research-
ers showed that syndecan-4 contributed to the increased 
endometrial cell activity, allowing for their development in 
the ectopic sites, whereas Schneider et al. [20] showed that 
syndecan-4 inhibited proliferation of these cells by reducing 
metalloproteinase-9 activity and interleukin-6 concentra-
tion. (IL-6). 
In conclusion, changes in concentrations of all the solu-
ble molecules evaluated during the study were demon-
strated in the peritoneal fluid of women with endometriosis. 
Key message
Syndecans and ICAMs are involved in regulation of the 
immune response and as a result of such changes, there may 
occur an abnormal response directed against the ectopic 
endometrium cells, facilitating their transfer and implanta-
tion in distant sites.
CONCLUSIONS
The conducted research led to the following conclu-
sions:
1. Changes in the concentration of the tested soluble cell 
adhesion molecules and syndecans, especially visible in 
the first and second degree of the disease, may indicate 
the participation of these molecules in the formation of 
endometriosis and indicate the intensification of migration 
and adhesion processes of endometrial cells in these stages 
of the disease.
2. Observed changes in the concentration of the tested 
soluble molecules, found in the peritoneal fluid of women 
with advanced endometriosis, may indicate the participa-
tion of these molecules in the development of the disease, 
by affecting the adhesion of endometrial cells to vascular 
endothelial cells and peritoneal mesothelium and migration 
to distant places of the body.
3. The assessed molecules, by participating in repair pro-
cesses, such as fibrosis and scarring, may contribute to the 
deformation of organs affected by the disease process and 
may allow the formation of blood vessels in the tissue of the 
ectopic endometrium, which allows these cells to survive 
outside the uterine cavity.
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